MIMESIS Newsletter #3: A novel systems biology approach to develop preclinical assets
MIMESIS NEWSLETTER #3, April 2018
A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses.
MIMESIS is a research and innovation project coordinated by ENYO Pharma and funded under the highly selective H2020 – SMEInstrument – Phase 2 call that aims at: “Dedicated support to biotechnology SMEs closing the gap from lab to market”. The MIMESIS project was launched on Nov 2016 for 2 years.
Genesis Drug Discovery 2018
10 – 11 May, 2018
Barcelona, Spain
“Genesis Drug Discovery (GDD) brings the most innovative event that aims to provide an open and stimulating scientific and cultural exchange that will give all the participants the opportunity to share their experiences, foster collaborations across industry and academia and evaluate emerging technologies across the globe.
Genesis Drug Discovery (GDD) provides a platform to promote international exchanges for drug discovery, and to accelerate the cooperation for new drug research and development in the global market.
Meet2Win 2018 – Oncology Business Convention
17-18 May, 2018
Bordeaux, France
“MATWIN organises in Bordeaux on May 17th and 18th 2018 the 4th edition of its European Business Convention entirely dedicated to open innovation, collaborative research and technology transfer: MEET2WIN.
Organized around one-to-one meetings and bringing together all the parties involved in oncology innovation, MEET2WIN offers the opportunity to meet representatives of big pharma companies, biotechs, start-up, project leaders researchers, clinicians, TTO’s, investors etc. to increase R&D private/public partnerships”.
2018 BIO International Convention
4-7 June, 2018
Boston, USA
“The BIO International Convention is hosted by the Biotechnology Innovation Organization, which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products”.
Latest Press Release 